These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2310408)

  • 1. The inhibition of glutamate dehydrogenase by some antipsychotic drugs.
    Couée I; Tipton KF
    Biochem Pharmacol; 1990 Mar; 39(5):827-32. PubMed ID: 2310408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sulphydryl groups of ox brain and liver glutamate dehydrogenase preparations and the effects of oxidation on their inhibitor sensitivities.
    Couée I; Tipton KF
    Neurochem Res; 1991 Jul; 16(7):773-80. PubMed ID: 1944766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ox brain glutamate dehydrogenase by perphenazine.
    Couée I; Tipton KF
    Biochem Pharmacol; 1990 Apr; 39(7):1167-73. PubMed ID: 2322301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine.
    Yoon HY; Hwang SH; Lee EY; Kim TU; Cho EH; Cho SW
    Biochimie; 2001 Sep; 83(9):907-13. PubMed ID: 11698113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of glutamate dehydrogenase by various drugs which affect behavior.
    Shemisa OA; Fahien LA
    Mol Pharmacol; 1971 Jan; 7(1):8-25. PubMed ID: 5552255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the effect of some psychotropic substancces on the activity of brain Na+, K+-ATPase in vitro].
    Tarve US; Paésalu EI; Tiakhepyl'd LIa
    Ukr Biokhim Zh; 1976; 48(3):326-31. PubMed ID: 134479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tranquilizers on the glutamate dehydrogenase-glutamate-oxalacetate transaminase complex.
    Shemisa OA; Fahien LA
    Mol Pharmacol; 1973 Nov; 9(6):726-35. PubMed ID: 4148653
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of glutamate dehydrogenase from ox brain and liver. Evidence that commercially available preparations of the enzyme from ox liver have suffered proteolytic cleavage.
    McCarthy AD; Walker JM; Tipton KF
    Biochem J; 1980 Nov; 191(2):605-11. PubMed ID: 7236213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of psychotropic drugs on cerebral Ca-activated ATPase in vitro].
    Karelson EI; Tarve US; Tiakhepyl'd LIa
    Biull Eksp Biol Med; 1981 May; 91(5):576-8. PubMed ID: 6114762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses.
    Gaertner I; Altendorf K; Batra A; Gaertner HJ
    J Clin Psychopharmacol; 2001 Apr; 21(2):215-22. PubMed ID: 11270919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of glutamate dehydrogenase by L-leucine.
    Couée I; Tipton KF
    Biochim Biophys Acta; 1989 Mar; 995(1):97-101. PubMed ID: 2923920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ox glutamate dehydrogenase. Comparison of the kinetic properties of native and proteolysed preparations.
    McCarthy AD; Tipton KF
    Biochem J; 1985 Aug; 230(1):95-9. PubMed ID: 4052048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenothiazines and phenothiazine metabolites on adenyl cyclase and the cyclic AMP response in the rat brain.
    Palmer GC; Manian AA
    Adv Biochem Psychopharmacol; 1974; 9(0):749-67. PubMed ID: 4365287
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chlorpromazine on glutamate dehydrogenase.
    Fahien LA; Shemisa O
    Mol Pharmacol; 1970 Mar; 6(2):156-63. PubMed ID: 4392129
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect on glutamate dehydrogenase activity after in vivo administration of pharmacological doses of haloperidol.
    Luengo de Borges E; Ryder E; Campos G
    Biochem Pharmacol; 1982 Apr; 31(7):1446-8. PubMed ID: 7092934
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-protein interactions: evaluation of the binding of antipsychotic drugs to glutamate dehydrogenase by quantitative affinity chromatography.
    Veronese FM; Bevilacqua R; Chaiken IM
    Mol Pharmacol; 1979 Mar; 15(2):313-21. PubMed ID: 38392
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of leu-enkephalin binding by neuroleptics.
    Somoza E; Bazán E; Galindo A
    Neuropsychobiology; 1982; 8(6):297-303. PubMed ID: 6131391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purification and properties of rat brain glutamate dehydrogenase.
    Chee PY; Dahl JL; Fahien LA
    J Neurochem; 1979 Jul; 33(1):53-60. PubMed ID: 222884
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG
    Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells.
    Nakazawa K; Ito K; Koizumi S; Ohno Y; Inoue K
    Br J Pharmacol; 1995 Nov; 116(6):2603-10. PubMed ID: 8590977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.